Skip to main
University-wide Navigation

'Behind the Blue': Leading the Way on Alzheimer’s Research With Linda Van Eldik of the Sanders-Brown Center on Aging

On this episode of "Behind the Blue," Sanders-Brown Center on Aging Director Linda Van Eldik joins UK Public Relations and Strategic Communications' Hillary Smith to discuss the larger game plan of finding a cure for Alzheimer’s and dementia.

UK Doctor's Need to Help Loved One Inspires New Sanders-Brown Video Series

A multi-disciplinary collaboration led by Dr. Peter Sawaya from the Sanders-Brown Center on Aging are in the process of producing a series of videos, aimed at primary caregivers for family members and loved ones living with dementia.

Sanders-Brown Hosts Discussion & Screening of Documentary Highlighting Robin Williams' Undiagnosed Dementia

The educational film titled, Spark, delves deeper into the disease, its biology, myriad of clinical symptoms and its impact on both the person with LBD and the primary caregiver. A post-screening panel will feature doctors from the Kentucky Neuroscience Institute.

UK Researcher Finds Alzheimer’s Patients ‘Get Hooked on a Feeling’ With Music

Research has found that music can elicit an extended emotional response in patients with Alzheimer’s-type dementia.

UK Study Potentially Links Low Blood Amylin Level to Reduced Progression of Alzheimer’s Disease

Florin Despa says that a major scientific goal is to understand whether the same factors that are involved in age-related metabolic disorders such as type-2 diabetes may also play a role in the development and progression of cognitive decline and dementia.

'Behind the Blue': Dr. Peter Nelson Discusses UK’s Leading Efforts on Alzheimer’s and Dementia Research

Dr. Peter Nelson, of the UK Sanders-Brown Center on Aging, has spent the last 15 years in the Commonwealth helping to lead the fight against Alzheimer’s and dementia inducing brain disease.

10th Annual Sanders-Brown Markesbery Symposium on Aging and Dementia Taking Place Virtually

In the sessions for both the scientific and community audience, attendees will have the opportunity to hear clinicians and researchers from UK and other institutions share current findings, trends, and latest updates on dementia and aging disorders.

Sanders-Brown Research Discovers New Pathway in TDP-43 Related Dementias

Selenica says their study is the first to provide a novel pathway and identify potential therapeutic targets for TDP-43 proteinopathies – especially in Alzheimer’s disease and the newly characterized form of dementia known as LATE.

Sanders-Brown Study Leads to Potential New Treatment Approach for Alzheimer’s Disease

Through the group's work, they found that the therapeutic targeting of TREM2 using a TREM2-activating antibody leads to the activation of microglia, recruitment of microglia to amyloid plaques, reduced amyloid deposition, and ultimately improved cognition.

UK’s Sanders-Brown, Penn Researchers Provide Insights into Newly Characterized Form of Dementia

“We used to think that aging-related memory and thinking decline meant one thing: a disease called Alzheimer’s disease. Now we know that the disease we were calling Alzheimer’s disease is actually many different conditions, often in combination."

Filter News